June 30 Deadline Extended Due to COVID-19 Disruptions
Purdue Pharma filed bankruptcy in September 2019 after facing liability for the opioid epidemic that killed nearly 450,000 people in the United States over a 19-year period. The company, which created OxyContin, agreed to settle upwards of 10,000 personal injury claims as part of its bankruptcy proceedings.
While the court opened claims to the public in February of this year, the claims process was originally set to close on June 30, 2020. With disruptions caused by the 2019 Coronavirus disease (COVID-19) pandemic, however, the judge overseeing Purdue’s bankruptcy case extended the deadline to July 30, 2020.
Purdue made the following statement about the deadline:
“[The July 30 deadline] balances our compassion for anyone who may have been impacted by COVID-19 shutdowns with the goal of providing the public benefits from a Purdue settlement as soon as possible.”
Funds from Purdue’s bankruptcy will pay a settlement with about two-dozen states and address approximately 6,800 claims filed on the company’s website. Purdue also faces about 4,200 personal injury claims from other avenues and more than 27,000 people filing with the Ad Hoc Group of Individual Victims.
What This Means for You
If you have not yet had the opportunity to make a claim against Purdue, now is the time. We encourage anyone who has lost a loved one to prescription painkillers to speak to our firm. Attorney Brett H. Oppenheimer is ready and willing to discuss your situation with you during a free consultation and take legal action if appropriate.
Purdue’s dangerous drugs stole hundreds of thousands of lives and permanently impacted many others. Don’t let the company get away with what it did to you and your family.
Exercise your right to take legal action and call Brett at (502) 242-8877 today. You can also click here to contact our legal team online.
All consultations are 100% free and confidential. We look forward to speaking to you and helping you hold Purdue accountable before it is too late.